This company has been marked as potentially delisted and may not be actively trading. Biofrontera (BFRA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Biofrontera AG’s Earnings Call Highlights Growth and Strategic AdvancesApril 23 at 8:36 PM | tipranks.comBiofrontera Full Year 2024 Earnings: €0.72 loss per share (vs €0.12 loss in FY 2023)April 18, 2025 | finance.yahoo.comBiofrontera AG Prepares to Release 2024 Financial ReportApril 17, 2025 | tipranks.comBiofrontera AG Reports 2024 Financial Results and Strategic Growth PlansApril 14, 2025 | tipranks.comBiofrontera AG Meets 2024 Forecasts and Outlines 2025 Financial ExpectationsApril 14, 2025 | tipranks.comBenchmark behält Kaufempfehlung für Biofrontera-Aktie bei, Kursziel 7 US-DollarMarch 24, 2025 | de.investing.comBiofrontera Inc. reports Q4 EPS (19c) vs $1.65 last yearMarch 22, 2025 | markets.businessinsider.comQ4 2024 Biofrontera Inc Earnings CallMarch 22, 2025 | finance.yahoo.comEarnings Call Transkript: Biofrontera verzeichnet Umsatzwachstum und strategische Veränderungen in Q4 2024March 21, 2025 | de.investing.comBiofrontera completes patient enrollment in Phase 3 study of AmeluzMarch 19, 2025 | markets.businessinsider.comBiofrontera enrols all subjects in trial of topical gel for actinic keratosesMarch 19, 2025 | msn.comBiofrontera says last patient completed one-year follow-up in Ameluz-PDT studyJanuary 9, 2025 | markets.businessinsider.comPTA-News: Biofrontera AG: BIOFRONTERA BERICHTET ÜBER DIE ERGEBNISSE DER ERSTEN NEUN MONATE DES JAHRES 2024November 30, 2024 | finanznachrichten.dePTA-News: Biofrontera AG: BIOFRONTERA BERICHTET -2-November 29, 2024 | finanznachrichten.deTelefonkonferenz zu den Quartalszahlen: Biofrontera verzeichnet moderates Umsatzwachstum im dritten Quartal 2024November 16, 2024 | de.investing.comBiofrontera stock climbs as drug-device succeeds in Phase III skin cancer trialNovember 1, 2024 | msn.comBiofrontera vermeldet Durchbruch in der Behandlung von HautkrebsOctober 31, 2024 | de.investing.comBiofrontera announces results in Phase 3 study of Ameluz-PDT for sBCCOctober 31, 2024 | markets.businessinsider.comRosalind Advisors, Inc. Reduces Stake in Biofrontera IncOctober 23, 2024 | uk.finance.yahoo.comLeverkusener Unternehmen: Wie Biofrontera sein Gewicht auf dem Pharma-Markt erhöhen willOctober 16, 2024 | msn.comBiofrontera schließt Datenbank der Phase-3-Studie zu sBCC für AnalyseOctober 15, 2024 | de.investing.comRoth/MKM setzt Kursziel für Biofrontera bei 16 US-Dollar, bekräftigt KaufempfehlungOctober 8, 2024 | de.investing.comBiofrontera (NASDAQ:BFRI) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comBiofrontera Second Quarter 2024 Earnings: €0.023 loss per share (vs €0.12 profit in 2Q 2023)October 2, 2024 | finance.yahoo.comBiofrontera Inc.: Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities ConferenceSeptember 25, 2024 | finanznachrichten.dePTA-News: Biofrontera AG: Erfolgreiche Hauptversammlung mit umfassender Zustimmung und neuen AufsichtsratsmitgliedernAugust 31, 2024 | finanznachrichten.deBiofrontera Inc. (BFRI) latest stock news & headlines – Yahoo FinanceAugust 27, 2024 | sg.finance.yahoo.comBiofrontera Inc. (NASDAQ:BFRI) Q2 2024 Earnings Call TranscriptAugust 16, 2024 | msn.comBenchmark Co. Reaffirms Their Buy Rating on Biofrontera (BFRI)August 16, 2024 | markets.businessinsider.comPTA-Adhoc: Biofrontera AG: Rechtsstreit um Import in die USA und daraus resultierende PrognoseJuly 21, 2024 | finanznachrichten.deBiofrontera Inc. (NASDAQ:BFRI) Q1 2024 Earnings Call TranscriptMay 17, 2024 | msn.comBFRI Stock Earnings: Biofrontera Misses EPS, Misses Revenue for Q1 2024May 15, 2024 | investorplace.comLeverkusener Pharma AG: Biofrontera regelt Nachfolge des starken Mannes Wilhelm ZoursMay 15, 2024 | msn.comAktien»Nachrichten»BIOFRONTERA AKTIE»PTA-News: Biofrontera AG: Biofrontera setzt Kapitalherabsetzung und Kapitalerhöhung umMay 8, 2024 | finanznachrichten.deBiofrontera Inc.: Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock WarrantsMay 3, 2024 | finanznachrichten.deBiofrontera files to sell 11.31M shares for holdersMay 3, 2024 | msn.comPTA-News: Biofrontera AG: Biofrontera berichtet über die Ergebnisse des Geschäftsjahres 2023May 1, 2024 | finanznachrichten.deLeverkusener Pharma-AG: Warum Biofrontera sich weiter von seinem Gründer absetztApril 4, 2024 | msn.comBiofrontera plant eine FinanzierungsrundeApril 4, 2024 | finanznachrichten.deQ4 2023 Biofrontera Inc Earnings CallMarch 19, 2024 | finance.yahoo.comBFRI Stock Earnings: Biofrontera Beats EPS, Misses Revenue for Q4 2023March 15, 2024 | investorplace.comBiofrontera Inc BFRIFebruary 28, 2024 | morningstar.comBiofrontera Up 56% After Revised Supply Agreement, Private Placement NewsFebruary 20, 2024 | marketwatch.comWhat's Going On With Biofrontera Stock?February 20, 2024 | msn.comBiofrontera FDA Review Advances Ameluz® Dosage ExpansionFebruary 6, 2024 | msn.comBiofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz to Permit Up to Three Tubes Per UseFebruary 5, 2024 | finanznachrichten.deBiofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per UseFebruary 5, 2024 | stockhouse.comPTA-News: Biofrontera AG: Ameluz® erhält Zulassungserweiterung für Anwendung mit künstlichem Tageslicht in der EU und in GroßbritannienFebruary 5, 2024 | finanznachrichten.deBiofrontera’s Pre-Funded Warrants Fully Exercised by InvestorFebruary 3, 2024 | msn.comBiofrontera Amends Agreement, Adjusts Payment ScheduleFebruary 3, 2024 | msn.com Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRA and its competitors with MarketBeat's FREE daily newsletter. Email Address BFRA Media Mentions By Week BFRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BFRA News Sentiment▼0.330.74▲Average Medical News Sentiment BFRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BFRA Articles This Week▼10▲BFRA Articles Average Week Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MBX News PVLA News ATAI News RNAC News CYRX News XOMA News PHAT News AQST News SEPN News MNPR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BFRA) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
